Treatment of small-cell lung cancer: American society of clinical oncology endorsement of the American college of chest physicians guideline

Journal of Clinical Oncology

Volumn 33, Issue 34, 2015, Pages 4106-4111

  Rudin, Charles M ^a   Ismaila, Nofisat ^b   Hann, Christine L ^c   Malhotra, Narinder ^d   Movsas, Benjamin ^f   Norris, Kim ^g   Pietanza, M Catherine ^a   Ramalingam, Suresh S ^h   Turrisi, Andrew T ^e   Giaccone, Giuseppe ⁱ  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b AMERICAN SOCIETY OF CLINICAL ONCOLOGY   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d Correct Care Solutions ^*  (United States)

^e Delta Medix   (United States)

^f HENRY FORD HOSPITAL   (United States)

^g Lung Cancer Foundation of America   (United States)

^h EMORY UNIVERSITY   (United States)

ⁱ GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN; MEDICAL SOCIETY; MULTIMODALITY CANCER THERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SMALL CELL LUNG CANCER; LUNG NEOPLASMS; ONCOLOGY; PROGNOSIS; SMALL CELL LUNG CARCINOMA;

HUMANS; LUNG NEOPLASMS; MEDICAL ONCOLOGY; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; SMALL CELL LUNG CARCINOMA;

EID: 84951812171     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.63.7918     Document Type: Article

References (9)

1. van Meerbeeck JP, Fennell DA, De Ruysscher DK: Small-cell lung cancer. Lancet 378:1741-1755, 2011
2. Byers LA, Rudin CM: Small cell lung cancer: Where do we go from here? Cancer 121:664-672, 2015
3. Govindan R, Page N, Morgensztern D, et al: Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: Analysis of the Surveillance, Epidemiologic, and End Results database. J Clin Oncol 24:4539-4544, 2006
4. Turrisi AT 3rd, Kim K, Blum R, et al: Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 340: 265-271, 1999
5. Jett JR, Schild SE, Kesler KA, et al: Treatment of small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed-American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143:e400S-e4019S, 2013 (suppl)
6. Seto T, Takahashi T, Yamanaka T, et al: Prophylactic cranial irradiation (PCI) has a detrimental effect on the overall survival (OS) of patients (pts) with extensive disease small cell lung cancer (EDSCLC): Results of a Japanese randomized phase III trial. J Clin Oncol 32:477s, 2014 (suppl 5s; abstr 7503)
7. Lara PN Jr., Natale R, Crowley J, et al: Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: Clinical and pharmacogenomic results from SWOG S0124. J Clin Oncol 27:2530-2535, 2009
8. Hanna N, Bunn PA Jr., Langer C, et al: Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer. J Clin Oncol 24:2038-2043, 2006
9. Zaloukal P, Cardenal F, Szczesna A, et al: A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease. Ann Oncol 21:1810-1816, 2010